Trinity biotech appoints diabetes care veteran as biosensor marketing director

Dublin, aug. 20, 2024 (globe newswire) -- trinity biotech plc (nasdaq: trib), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announces the appointment of david ouston as biosensor marketing director. mr. ouston brings a wealth of commercial experience driving the growth of glucose monitoring devices at large, established companies across global markets.
TRIB Ratings Summary
TRIB Quant Ranking